Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 34

1.

Practical considerations for managing breakthrough psychosis and symptomatic worsening in patients with schizophrenia on long-acting injectable antipsychotics.

Correll CU, Sliwa JK, Najarian DM, Saklad SR.

CNS Spectr. 2018 Dec 27:1-17. doi: 10.1017/S1092852918001098. [Epub ahead of print]

PMID:
30587268
2.

Time to onset and time to resolution of extrapyramidal symptoms in patients with exacerbated schizophrenia treated with 3-monthly vs once-monthly paliperidone palmitate.

Mathews M, Nuamah I, Savitz AJ, Hough DW, Najarian D, Kim E, Gopal S.

Neuropsychiatr Dis Treat. 2018 Oct 25;14:2807-2816. doi: 10.2147/NDT.S175364. eCollection 2018.

3.

Community pharmacists and mental illness: a survey of service provision, stigma, attitudes and beliefs.

Giannetti V, Caley CF, Kamal KM, Covvey JR, McKee J, Wells BG, Najarian DM, Dunn TJ, Vadagam P.

Int J Clin Pharm. 2018 Oct;40(5):1096-1105. doi: 10.1007/s11096-018-0619-7. Epub 2018 Jun 4.

PMID:
29862460
4.

An assessment of injection site reaction and injection site pain of 1-month and 3-month long-acting injectable formulations of paliperidone palmitate.

Kern Sliwa J, Savitz A, Nuamah I, Mathews M, Gopal S, Elefant E, Najarian D, Alphs L.

Perspect Psychiatr Care. 2018 Oct;54(4):530-538. doi: 10.1111/ppc.12267. Epub 2018 Feb 14.

PMID:
29446084
5.

A comparison study of bioanalytical methods for detection and characterization of anti-velaglucerase alfa antibodies.

Najarian DR, Hilton K, McCauley T, Qiu Y.

Bioanalysis. 2017 May;9(10):775-786. doi: 10.4155/bio-2016-0274. Epub 2017 Apr 28.

PMID:
28453301
6.

Soluble adenylyl cyclase (sAC) immunostaining distinguishes pseudomelanocytic nests in lichenoid tissue reaction.

Hall LD, Bodendorf MO, Najarian DJ, Ferringer T, Elston D.

J Cutan Pathol. 2015 Mar;42(3):232-5. doi: 10.1111/cup.12455. Epub 2014 Dec 23. No abstract available.

PMID:
25534227
7.

Annular leukocytoclastic vasculitis associated with sorafenib administration.

Najarian DJ, Packianathan V, Zeitouni NC.

J Drugs Dermatol. 2010 Jun;9(6):697-8.

PMID:
20645534
8.

Recurrent giant cell fibroblastoma treated with Mohs micrographic surgery.

Najarian DJ, Morrison C, Sait SN, Meguerditchian AN, Kane J 3rd, Cheney R, Zeitouni NC.

Dermatol Surg. 2010 Mar;36(3):417-21. doi: 10.1111/j.1524-4725.2009.01459.x. Epub 2010 Jan 19. No abstract available.

PMID:
20100251
9.

JAAD Grand Rounds quiz. Numerous hyperpigmented macules of the oral mucosa.

Lema B, Najarian DJ, Lee M, Miller C.

J Am Acad Dermatol. 2010 Jan;62(1):171-3. doi: 10.1016/j.jaad.2008.11.009. No abstract available.

PMID:
20082906
10.

A case of mucous membrane plasmacytosis successfully treated with cryotherapy.

Najarian DJ, Rao BK, Pappert AS.

Dermatol Online J. 2008 Feb 28;14(2):6.

11.

Hypozincemia and hyperzincuria associated with necrolytic acral erythema.

Najarian DJ, Najarian JS, Rao BK, Pappert AS.

Int J Dermatol. 2008 Jul;47(7):709-11. doi: 10.1111/j.1365-4632.2008.03586.x. No abstract available.

PMID:
18613880
12.

New-onset, debilitating arthritis in psoriasis patients receiving efalizumab.

Myers WA, Najarian D, Gottlieb AB.

J Dermatolog Treat. 2006;17(6):353-4.

PMID:
17853308
13.

Zinc deficiency associated with necrolytic acral erythema.

Najarian DJ, Lefkowitz I, Balfour E, Pappert AS, Rao BK.

J Am Acad Dermatol. 2006 Nov;55(5 Suppl):S108-10. No abstract available.

PMID:
17052522
14.

Treatment of patients with osteoarthritis with rofecoxib compared with nabumetone.

Weaver AL, Messner RP, Storms WW, Polis AB, Najarian DK, Petruschke RA, Geba GP, Tershakovec AM.

J Clin Rheumatol. 2006 Feb;12(1):17-25.

PMID:
16484875
15.

Assessment of polymorphic variants in the melanocortin-1 receptor gene with cutaneous pigmentation using an evolutionary approach.

Kanetsky PA, Ge F, Najarian D, Swoyer J, Panossian S, Schuchter L, Holmes R, Guerry D, Rebbeck TR.

Cancer Epidemiol Biomarkers Prev. 2004 May;13(5):808-19.

16.

Efficacy and safety of rofecoxib 12.5 mg versus nabumetone 1,000 mg in patients with osteoarthritis of the knee: a randomized controlled trial.

Kivitz AJ, Greenwald MW, Cohen SB, Polis AB, Najarian DK, Dixon ME, Moidel RA, Green JA, Baraf HS, Petruschke RA, Matsumoto AK, Geba GP; Protocol 085 Study Investigators.

J Am Geriatr Soc. 2004 May;52(5):666-74.

PMID:
15086644
17.

Efficacy and safety profile of treatment with etoricoxib 120 mg once daily compared with indomethacin 50 mg three times daily in acute gout: a randomized controlled trial.

Rubin BR, Burton R, Navarra S, Antigua J, LondoƱo J, Pryhuber KG, Lund M, Chen E, Najarian DK, Petruschke RA, Ozturk ZE, Geba GP.

Arthritis Rheum. 2004 Feb;50(2):598-606.

18.

Connections between psoriasis and Crohn's disease.

Najarian DJ, Gottlieb AB.

J Am Acad Dermatol. 2003 Jun;48(6):805-21; quiz 822-4. Review.

PMID:
12789169
19.

EmtA, a rRNA methyltransferase conferring high-level evernimicin resistance.

Mann PA, Xiong L, Mankin AS, Chau AS, Mendrick CA, Najarian DJ, Cramer CA, Loebenberg D, Coates E, Murgolo NJ, Aarestrup FM, Goering RV, Black TA, Hare RS, McNicholas PM.

Mol Microbiol. 2001 Sep;41(6):1349-56.

20.

Interaction of glutathione S-transferase M1 and T1 genotypes and malignant melanoma.

Kanetsky PA, Holmes R, Walker A, Najarian D, Swoyer J, Guerry D, Halpern A, Rebbeck TR.

Cancer Epidemiol Biomarkers Prev. 2001 May;10(5):509-13.

21.

Growth inhibition caused by overexpression of the structural gene for glutamate dehydrogenase (gdhA) from Klebsiella aerogenes.

Janes BK, Pomposiello PJ, Perez-Matos A, Najarian DJ, Goss TJ, Bender RA.

J Bacteriol. 2001 Apr;183(8):2709-14.

22.

Effects of mutations in ribosomal protein L16 on susceptibility and accumulation of evernimicin.

McNicholas PM, Mann PA, Najarian DJ, Miesel L, Hare RS, Black TA.

Antimicrob Agents Chemother. 2001 Jan;45(1):79-83.

23.

Evernimicin binds exclusively to the 50S ribosomal subunit and inhibits translation in cell-free systems derived from both gram-positive and gram-negative bacteria.

McNicholas PM, Najarian DJ, Mann PA, Hesk D, Hare RS, Shaw KJ, Black TA.

Antimicrob Agents Chemother. 2000 May;44(5):1121-6.

24.

Olanzapine increases weight and serum triglyceride levels.

Osser DN, Najarian DM, Dufresne RL.

J Clin Psychiatry. 1999 Nov;60(11):767-70.

PMID:
10584766
25.

Collection of genomic DNA by buccal swabs for polymerase chain reaction-based biomarker assays.

Walker AH, Najarian D, White DL, Jaffe JF, Kanetsky PA, Rebbeck TR.

Environ Health Perspect. 1999 Jul;107(7):517-20.

26.

Separation and analysis of DNA sequence reaction products by capillary gel electrophoresis.

Cohen AS, Najarian DR, Karger BL.

J Chromatogr. 1990 Sep 7;516(1):49-60.

PMID:
2286628
27.

Composite in situ vein bypass for upper extremity revascularization.

Guzman-Stein G, Schubert W, Najarian DW, Press BH, Cunningham BL.

Plast Reconstr Surg. 1989 Mar;83(3):533-6.

PMID:
2919206
28.

Rapid separation of DNA restriction fragments using capillary electrophoresis.

Cohen AS, Najarian D, Smith JA, Karger BL.

J Chromatogr. 1988 Dec 23;458:323-33.

PMID:
2853173
29.

Rapid separation and purification of oligonucleotides by high-performance capillary gel electrophoresis.

Cohen AS, Najarian DR, Paulus A, Guttman A, Smith JA, Karger BL.

Proc Natl Acad Sci U S A. 1988 Dec;85(24):9660-3.

30.

DNA sequence and transcript mapping of MOD5: features of the 5' region which suggest two translational starts.

Najarian D, Dihanich ME, Martin NC, Hopper AK.

Mol Cell Biol. 1987 Jan;7(1):185-91.

31.

Isolation and characterization of MOD5, a gene required for isopentenylation of cytoplasmic and mitochondrial tRNAs of Saccharomyces cerevisiae.

Dihanich ME, Najarian D, Clark R, Gillman EC, Martin NC, Hopper AK.

Mol Cell Biol. 1987 Jan;7(1):177-84. Erratum in: Mol Cell Biol 1987 May;7(5):2035.

32.
33.

In vitro transcription and promoter strength analysis of five mitochondrial tRNA promoters in yeast.

Wettstein-Edwards J, Ticho BS, Martin NC, Najarian D, Getz GS.

J Biol Chem. 1986 Feb 25;261(6):2905-11.

34.

A mutation in the tRNAAsp gene from yeast mitochondria. Effects on RNA and protein synthesis.

Miller DL, Najarian DR, Folse JR, Martin NC.

J Biol Chem. 1981 Oct 10;256(19):9774-7.

Supplemental Content

Loading ...
Support Center